Labtech (688056): R&D continues to consolidate new industry expansion and show initial results
Libretech (688056): Stable revenue growth caused by multiple factors, short-term gross margin was under pressure, consolidating R&D strength and accumulating long-term development
Libretech (688056): R&D continues to establish projects and gradually expand product lines
Libretech (688056) 2023 three-quarter report review: good business conditions, orderly expansion of downstream markets
Libertec (688056): Increased raw material price+new production line put pressure on the profit side, business blossomed more and fueled long-term development
Libertec (688056): Good business condition, new products launched in an orderly manner
Libertec (688056): Full coverage of inorganic testing products 2023H1, revenue increased 26%
Libertec (688056): R&D investment continues to break through and business conditions continue to improve
Levertech (688056): The Darkest Hour Is Over Expected Mass Spectrometry
Levertech (688056): Post-epidemic operations are gradually picking up, and localization of high-end mass spectrometry is accelerating
Levertech (688056) 2022 Annual Report and 2023 Quarterly Report Reviews: Pretreatment Products Made Breakthroughs Overseas; Mass Spectrometer Categories Expanded Smoothly
Levertech (688056): Mass spectrometer industrial application company enters a broad new market
Libertyco (688056): The impact of the epidemic on revenue is confirmed to be selected as a specialist, special and new, which can be expected in the future
Libertyco (688056) Third Quarterly Report Review: The Impact of the Pandemic Suppresses Performance Expansion Teams and Causes Cost Increases
Libertyco (688056) Interim Report Review: Mass Spectrometer Approved Business Model Expands
Levertech (688056): The pandemic drags down performance, H2 expects a rebound
Lebertek (688056): the epidemic leads to short-term pressure on performance and the gradual release of mass spectrometry products.
Leibertek (688056): continuously strengthen R & D investment in mass spectrometer sales are worth looking forward to
Lebertek (688056): research and development-oriented, never forget the original ideal and ambition mass spectrometer to take advantage of the opportunity to start a new journey
Levertech (688056): Breakthrough in ICP-MS products is expected to open up room for growth
No Data